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dictors of long-term mortality were early PVIE (RR = 2.14), comorbidity (RR =3), CHF
(RR= 4.19), and S aureus (RR = 2). After a mean 32 months follow-up, only 61 (58%) pts
are still alive.
Conclusion.
1 – PVIE is still associated with high in-hospital and long-term mortality and needs close
follow-up after the initial in-hospital stay.
2 – CHF, S aureus, severe regurgitation, and complicated PVE are associated with poor
outcome.
3 – Half PVIE can be treated without surgery with similar mortality than operated pts.
4 - However, surgery during the acute phase is associated with a better outcome in pts
with S aureus infection and in pts with > 1 prognostic marker. Early surgical therapy is
mandatory in these pts.
1010-139 Echocardiographic Characteristics Predictive of 
Successful Repair in Patients With Isolated Tricuspid 
Aortic Valve Regurgitation
Patrick J. Nash, Eugene Vitvitsky, Delos M. Cosgrove, III, Gosta Pettersson, Richard A. 
Grimm, Cleveland Clinic Foundation, Cleveland, OH
Background: There is increasing interest in valve sparing operations for patients with
isolated severe aortic regurgitation (AR). Features that are predictive of repair of tricuspid
aortic valves with intrinsic cusp pathology are not well defined.
Methods: We reviewed all intraoperative transoesophageal echos performed on patients
with isolated AR and trileaflet valves undergoing surgery at our institution over a three-
year period (2000- 2002). Those with evidence of aortic dissection, primary ascending
aortic root dilatation and those where endocarditis was the primary etiologic factor were
excluded.
Results: We identified 114 patients (Mean age 59+/-15yrs; 79% male), 39 (34.2%) had
isolated aortic cusp prolapse and 73 (64%) had restricted cusp motion as the primary
mechanism of AR. Valve repair was performed in 26 (22.8%).Two of these patients had
failed repairs requiring valve replacement. Repair was more likely in younger patients,
those with leaflet prolapse, tless leaflet edge thickening and less commissural calcifica-
tion. By multivariate analysis, eccentric AR jet direction and less leaflet edge thickening
(</= 3mm), emerged as independent determinants of likelihood of successful valve repair
Conclusions: A number of echo features predict valve reparability in patients with trileaf-
let aortic valves, intrinsic valve pathology and primary isolated AR, with eccentric regur-
gitant jet direction and less leaflet edge thickness being the most important.
1010-140 Influence of Surgical Treatment of Atrial Fibrilation on 
Late Morbi-Mortality After Correction of Mitral Valve 
Lesions Associated With Chronic Atrial Fibrillation
Renato A.k. Kalil, Gustavo G. Lima, Daniel L. Faria-Corrêa, Rogério Abrahão, Maurice 
Formigheri, Marcelo Miglioransa, Gustavo Vanni, Paulo R. Prates, João R.M. Sant'Anna, 
Ivo A. Nesralla, Institute of Cardiology of Rio Grande do Sul / FUC, Porto Alegre, RS, 
Brazil
Background: Atrial Fibrillation (AF) has been associated with increased morbi-mortality.
Surgical treatment has been delivering consistent benefits. We intended to evaluate the
benefit, in long term, of the maintenance of the sinus rhythm achieved by surgical treat-
ment of AF associated with mitral valve correction.
Methodology: Retrospective study of 138 patients with chronic AF and mitral valve dis-
ease, operated between 1994 and 2002. Sixty-one patients underwent isolated mitral
valve surgery, 51 associated with modified COX procedure and 26 associated with isola-
tion of pulmonary veins (IPV) by an elyptical incision around all their 4 orifices, by simple
"cut and sew" technique. The mean age was 50±12 years and the average follow up was
49±26 months in isolated mitral valve surgery, 55±28 months on mod-COX group and
26±10 months on IPV. Death from cardiovascular cause was analized, as well as throm-
boembolism, hemorrhage, arrhythmia and reoperation at late follow-up.
Results: At 24 months of follow up, the rhythm was sinus in 87.5% on IPV, 72.7% on
mod-COX and 23.3% on mitral alone (p<0.001). As for the morbi-mortality, 30 (21.9%)
patients had some event:13.9% of the patients on sinus rhythm and 30.8% on non-sinus
(p=0.014). Trombo-hemorrhagic events occurred in 1.4% of the sinus rhythm patients
and in 18.5% of those not in sinus rhythm (p<0.001). 
Conclusion: IPV and mod-COX groups had a larger reversion rate to sinus rhytm at 24
months. Patients on sinus rhythm had less long term trombo-hemorrhagic events. There
is objective benefit expressed in lower morbi-mortality when surgical treatment of AF is
added to mitral valve surgery.
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1030-135 Impact of Wide Pulse Pressure With and Without High 
Systolic Blood Pressure on Clinical Outcomes in 
Chronic Severe Aortic Regurgitation
Phyllis G. Supino, Jeffrey S. Borer, Jacek Preibisz, Clare Hochreiter, Karlheinz Schuleri, 
Richard B. Devereux, Mary J. Roman, Paul Kligfield, Amanda D. Konstam, Weill Medical 
College of Cornell University, New York, NY
Background: For over a century, pulse pressure has been recognized as a clinical sign
of the severity of aortic regurgitation (AR) but its predictive value remains unclarified. We
previously showed that systolic hypertension predicts adverse outcomes among patients
(pts) with chronic severe AR. However, the relative prognostic importance of the systolic
(SBP), diastolic (DBP), and pulse (SBP-DBP [PP]) pressures is undefined. Methods:
Therefore, among 64 pts with chronic severe AR (83% male, age at entry: 44±15 yrs,
87% non-rheumatic) who were asymptomatic with nl LV ejection fraction (EF) at rest by
radionuclide cineangiography at study entry and were followed 7±4 event-free yrs, we
related SBP, DBP and PP, defined during physical exam at study entry, and their interac-
tions, to subsequent cardiac events (CE). Results: During followup, 2 pts died suddenly,
15 pts developed heart failure(CHF)±LV dysfunction, and 5 developed LV dysfunction
alone. By univariate analysis, both SBP (p=.009) and PP (p<.02), but not DBP (NS) pre-
dicted CE. Multivariate analysis revealed a positive interaction between SBP and PP indi-
cating a synergistic effect on outcomes even when adjusted for age, gender and
rheumatic vs nonrheumatic etiology (p=.0002). Thus, pts with both SBP>140 and PP >
82 (N=16) had a 5-fold increased risk of CE (Avg. Annual Risk [AAR]=15.6) vs. pts with
SBP>140 and PP<82 (N=9, AAR=3.2, p<.03); no PP-associated risk was found among
the 39 pts with SBP<140 (NS). Conclusions: SBP and PP each predict CE risk among
asymptomatic pts with severe AR and nl LVEFrest irrespective of etiology. Wide PP in the
setting of high SBP further concentrates this risk but DBP does not affect risk. Further
research mustdetermine the relation of pp to other prognostically important variables and
whether currently available therapeutic interventions to lower pp and/or sbp are clinically
beneficial in this population.
1030-136 Echocardiographic Presence of Mitral Annular 
Calcification Predicts Increased Mortality in Patients 
With Normal Left Ventricular Ejection Fraction
Gustavo Cardenas, Mark X. Jiang, Nirankar V. Metha, Richard Milani, Christian S. 
Breburda, Heart and Vascular Institute, Ochsner Clinic Fdn, New Orleans, LA
Mitral annular calcification is frequently noted on echocardiographic examinations, how-
ever its prognostic significance is not well defined in patients with normal left ventricular
function. We sought to investigate the correlation of echocardiographic mitral annular cal-
cification (MAC) and overall mortality in a large clinical population. We hypothesized that
presence and degree of MAC in patients with normal left ventricular ejection fraction
does adversely affect mortality.
Methods: 52,129 patients, referred to our institution for echocardiographic examinations
were evaluated. MAC was graded as absent, mild (spotty calcification of the annulus), or
as marked (extensive circumferential calcium protruding into the mitral annular plane) by
qualitative visual analysis. The observation period for mortality rate was 5 years.
Results: Mean age was 60.8 ± 15 years (48% m, 52% f), mean BMI was 29.5 ± 18 kg/
cm2, mean EF was 61 ± 4 %. MAC was absent in 43,496 patients (83%), was mild in
7825 pts (15%) and was marked in 808 pts (1.55 %). During the observation period over-
all mortality rate was 6.47 %, was 5.4 % in the absence of MAC, was 11.5 % with mild
MAC (chi2 = 424, p less than 0.0001), odds ratio (OR) = 2.3 (2.11-2.48), and was 16.34
% with marked MAC (chi2 = 181, p less than 0.0001), OR 3.43 (2.83-4.16).
A multivariate logistic regression model revealed MAC (OR = 1.5), age (OR = 1.03), male
gender (OR = 0.82) and ejection fraction (OR = 0.96) as significant independent predic-
tors for mortality (chi2 = 1053, p less than 0.0001).
Conclusion: Echocardiographic presence and degree of mitral annular calcification in
patients with normal left ventricular ejection fraction constitutes a significant independent
and the strongest predictor of mortality, when compared with age, male gender, BMI and
left ventricular ejection fraction.
1030-137 Clinical Presentation and Outcome of Tricuspid 
Regurgitation Due to Flail Leaflets
David Messika-Zeitoun, Helen Thomas, Michael Bellamy, Christopher Scott, Christophe 
Tribouilloy, Joseph Dearani, A. Jamil Tajik, Hartzell Schaff, Maurice Enriquez-Sarano, 
Mayo Clinic, Rochester, MN
Background: Tricuspid regurgitation (TR) has the reputation of being well tolerated but
most studies have focused on functional TR. Little is known about TR due to organic
valve disease particularly regarding prognosis. Tricuspid flail leaflet (FL) is an important
causative mechanism of organic TR as it causes uniformly high degree of regurgitation
and can be easily diagnosed by 2D-echocardiography.
Methods: We analyzed etiology and clinical outcome of TR due to FL diagnosed by 2D-
echocardiography in 60 patients between 1980 and 2000.
Repair Replacement
Age 50 +/- 15 62 +/- 14 p = 0.006
Mechanism – Prolapse 66.6% 25.6% p = 0.002
Mechanism – Central Defect/Restricted leaflet 
motion
29.1% 70.8% p = 0.002
Jet Direction – Eccentric 65.2% 29.6% p = 0.002
Leaflet Edge thickness of < 0.3cm 38.1% 93.5% p < 0.0001
Commissural Calcium 14.3% 70.3% p < 0.0001
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Results: Mean age at presentation was 51±26 and 37 patients were male. TR grade was
>3 in 92%. Main etiology was traumatic (n=37, 62%), non-iatrogenic in 19 (mostly related
to motor vehicle accident) and iatrogenic in 18 (mostly related to right ventricular biopsy).
Clinical presentation was often severe: 57% were in NYHA class >II, 33% had a history
of congestive heart failure (CHF) and 40% of atrial fibrillation (AF). Compared to
expected survival of US matched population, an excess mortality was observed even
after exclusion of 11 patients in whom associated diseases could have affected the sur-
vival (3.8% yearly, p=0.02). Patients asymptomatic at presentation also experienced a
high incidence of TR-related complications (symptoms or CHF, AF, surgery or death,
75±15% at 10 years) predicted by severe enlargement of right-sided chambers (at 5
years 86±9 vs. 39±11%, p<0.01). Natural history started from date of occurrence of the
flail also showed high complication rates (69±9% at 15 years). Etiology of TR did not
influence the outcome. Tricuspid surgery was performed in 33 patients (55±7% at 5
years) and repair was performed in most patients (82%) with low mortality (3%). Despite
frequently refractory AF, surgery allowed symptomatic improvement in 88%.
Conclusion: TR due to FL is a serious disease associated with excess mortality and
high morbidity. Tricuspid valve repair can often be performed with low risk allowing symp-
tomatic improvement. These results suggest that surgery should be considered early in
the course of the disease before occurrence of intractable heart failure, particularly in
patients with dilatation of right-sided chambers.
1030-138 Valvular Regurgitation Predicts Cardiovascular 
Mortality and Morbidity Among American Indians: The 
Strong Heart Study
Felizen S. Agno, Marcello Chinali, Lyle G. Best, Jonathan N. Bella, Barbara V. Howard, 
Elisa T. Lee, Richard B. Devereux, Weill Medical College of Cornell University, New York, 
NY
Background: Valvular regurgitation has been extensively examined in cross-sectional
studies but there are few data on its association with cardiovascular (CV) morbidity and
mortality in population-based samples. Methods: In 3,199 participants (60±8 years, 64%
women, 45% hypertensive, 47% diabetic) without prevalent CV disease, valvular stenosis
or prostheses who had echocardiograms in the 2nd Strong Heart Study examination, Cox
proportional hazards models were used to estimate hazard ratios (HRs) associated with
isolated mitral regurgitation (MR) or aortic regurgitation (AR) or combined MR and AR
(MAR) for each outcome. Results: Among participants, 587 (18.3%) had MR of any
degree, 198 (6.2%) had any degree of AR and 139 (4.3%) had MAR. During 9,926 per-
son-years of follow-up, 9.0% of participants (N=289) had CV events, 12.4% (N=396) died
(28.9% of CV causes and 5.8% died suddenly). In multivariable analyses controlling for
age, gender, systolic and diastolic blood pressure, body mass index, glucose, insulin,
creatinine, lipid profile, smoking, diabetes and hypertension, MAR but not isolated MR or
AR was associated with increased risks of incident CV events (HR 2.0), CV death (HR
2.8), sudden death (HR 5.9) and all-cause death (HR 1.8)(all p<0.05, see Table for 95%
CIs). Conclusions: In a population-based sample of middle-aged and elderly adults, co-
existent MR and AR (MAR) is prevalent (4.3%) and is independently associated with
increased risk of all-cause and CV death and events. 
1030-139 Prevalence and Correlates of Mitral Regurgitation in 
Hypertensive Patients: The HyperGen Study
Zhi Bin Li, Richard B. Devereux, Jennifer E. Liu, Dalane W. Kitzman, Albert Oberman, 
Paul N. Hopkins, Charles C. Gu, Donna K. Arnett, Weill Medical College of Cornell 
University, New York City, NY
Background: The prevalence and correlates of mitral regurgitation (MR) for hypertensive
patients in a population-based sample have not been well described.
Methods: MR was accessed by color Doppler of echocardiograms in 2172 hypertensive
and 367 normotensive adults from the population-based Hypertension Genetic Epidemi-
ology Network (HyperGEN) study.
Results: Mild MR was present in 15.3%, moderate in 2.5% and severe in 1.0% of hyper-
tensive participants, versus 15.7%, 8.5% and 0.3% of normotensive adults (p=NS).
Among hypertensive patients, MR prevalence was associated with older age. After
adjusting for the effect of age, MR was associated with Caucasian ethnicity, lower body
mass index, higher systolic blood pressure, coronary artery disease, larger left atrium
size, mitral and aortic valve diseases (all p<0.05). In ANOVA and multivariate analyses
adjusted by covariates such as age, gender, body mass index, blood pressure, aortic
regurgitation, mitral valve and coronary artery disease, mild MR was associated with
increased LV mass index (95±23 vs. 87±19 g/m2) (p<0.01); moderate to severe MR were
associated with increased LV diastolic diameter (5.5±0.9 vs. 5.1±0.5 cm) and LV mass
index (105±26 vs. 87±19 g/m2), lower LV systolic function indices such as ejection frac-
tion (54±15 % vs. 62±7 %) and stress-corrected midwall shortening (99±22 % vs.
105±12 %) (all p<0.05). MR prevalence was not associated with gender, controlled or
uncontrolled hypertension, antihypertensive medication, diabetes, serum creatinine,
albumin, cholesterol and triglyceride levels (all p=NS).
Conclusions: This study showed that MR prevalence was nearly 19% among hyperten-
sive patients. It was associated with older age.After adjusting the effect from age, it was
also associated with Caucasian ethnicity, larger left atrial size, cardiovascular diseases,
systolic blood pressure difference and lower body mass index. The presence and severity
of MR were positively related to increased LV hypertrophy, greater LV dilatation and dys-
function. MR prevalence was unrelated to gender difference, diabetes, isolated hyperten-
sion and antihypertensive medication.
1030-140 Patent Foramen Ovale: A New Factor Associated With 
Progression of Carcinoid Heart Disease
Nicolas Mansencal, Emmanuel Mitry, Franck Digne, Jean-François Forissier, Thierry 
Joseph, Pascal Lacombe, Philippe Rougier, Olivier Dubourg, Hôpital Ambroise Paré, 
Boulogne, France
Background: Several studies have demonstrated that serotonin and chemotherapy were
associated with the progression of carcinoid heart disease (CHD). The aim of this pro-
spective study was to assess the role of patent foramen ovale in the progression of CHD.
Method: In 30 consecutive patients (mean age 58 years, range 40-74, 50% women) with
carcinoid syndrome, we performed serial (77) echocardiographic studies. The echocar-
diographic following parameters were systematically assessed: 1) right-CHD, 2) left-CHD,
3) right to left shunting through a patent foramen ovale (PFO) using contrast echocardio-
graphy at rest and after cough test or Valsalva maneuver.
Results: Mean follow-up was 24 months (range: 12-48 months). At baseline, echocardio-
graphy revealed 10 pts (33%) with right-CHD and 4 pts (13%) with left-CHD (Table). At
the end of follow-up, the incidence of right-CHD, left-CHD was respectively 53% (16 pts)
and 33% (10 pts). The baseline and follow-up frequencies of PFO were respectively 27%
(8 pts) and 43% (13 pts). The presence of PFO was strongly associated with the progres-
sion of both right- and left-CHD (p=0.001). The metabolite of serotonin (urinary 5-HIAA,
p=0.002) and plasmatic chromogranin A (p=0.002) levels were also predictive factors of
progression but not chemotherapy (p=0.7).Conclusion: Our data suggest that PFO is a
new important factor of carcinoid heart disease progression and should be systematically
researched by serial contrast echocardiographic studies.
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1048-136 Long-Term Results With the St. Jude Medical Aortic 
Valve: A 25-Year Experience
Robert W. Emery, Kit V. Arom, Christopher Krogh, Lyle D. Joyce, Minnesota 
Cardiovascular & Thoracic Surgeons LLC, St. Paul, MN
BACKGROUND: From 10/77 – 10/02, 2983 patients (age range 17-94 years, average
age 65 ± 13) underwent aortic valve replacement (AVR) with the St. Jude Medical (SJM)
heart valve. Concomitant coronary bypass was performed in 1239 (42%) patients.
METHODS: Cardiac Surgical Associates has maintained an independent database of
our patients having valve replacement with the SJM prosthesis since the world’s first
implant in 10/77. Patients were contacted by questionnaire and/or phone from 11/02
through 6/03. Hospital course and valve-related events were verified by patient chart
review and/or physician contact.
RESULTS: Operative mortality was 4% (AVR 3%; AVR/CAB 6% of which 15 (12% were
valve related. Total follow-up (94%) was 21,742 patient years (range 1 month to 24.8
years, average 7 ± 5 years). At 25 years, overall patient freedom from late mortality was
61% and from late valve-related mortality 93%. Freedom from thromboembolic events
was 86%; from bleeding events 81%; from endocarditis: 98%, and from valve thrombosis
99%; and from reoperation 99%. Reoperation was carried out in 51 patients (2%) for
suture closure of paravalvular leak (n=4), valve replacement (34) and debridement of
valve (13). There were no structural failures.
CONCLUSION: The SJM valve has proven to be an effective and durable heart valve
prosthesis with a low event rate over the long term.
1048-137 Impact of Valve Prosthesis-Patient Mismatch on 
Pulmonary Arterial Pressure After Mitral Valve 
Replacement
Mingzhou Li, Jean G. Dumesnil, Patrick Mathieu, Philippe Pibarot, Laval University, 
Sainte-Foy, PQ, Canada
Background: Pulmonary arterial (PA) hypertension is a serious complication of mitral
valve disease and it is a major risk factor for poor outcome following mitral valve replace-
ment (MVR). We hypothesised that valve prosthesis-patient mismatch (PPM) might be a
determinant of PA hypertension after MVR. Methods: Systolic PA pressure was mea-
sured by Doppler-echocardiography in 56 patients with normally functioning mitral pros-
thetic valves at 24±14 months after MVR. Mitral valve effective orifice area (MVA) was
determined by the continuity equation and indexed for body surface area. Results: Sev-
enty one (71) percent of patients had PPM defined as an indexed MVA < 1.2 cm2/m2.
Thirty patients (54%) had a systolic PA pressure > 40 mmHg and 13 patients (24 %) had
a systolic PA pressure > 50 mmHg. There was a good correlation (r=0.64) between sys-
tolic PA pressure and indexed MVA (see figure). The average systolic PA pressure and
prevalence of PA hypertension (PA pressure > 40 mmHg) were 34±8 mmHg and 19% in





Combined MR and AR
HR (95% CI)
CV Events 1.3 (0.9 to 1.8) 1.3 (0.8 to 2.1) 2.0 (1.2 to 3.2)
CV Death 1.4 (0.8 to 2.3) 1.4 (0.7 to 2.8) 2.8 (1.4 to 5.5)
Sudden Death 2.2 (0.7 to 7.1) 1.2 (0.2 to 6.5) 5.9 (1.4 to 25.6)
All-cause Death 1.2 (0.9 to 1.6) 1.1 (0.7 to 1.6) 1.8 (1.2 to 2.8)
